News
-
-
-
PRESS RELEASE
ProteinQure Announces A Breakthrough Therapeutic with Remarkable Efficacy in Heterogenous Patient-Derived Xenograft Models of Triple-Negative Breast Cancer to be presented at AACR
ProteinQure announces breakthrough in triple-negative breast cancer treatment through novel Peptide Drug Conjugate with exceptional efficacy in lab experiments -